The FTC’s investigation of PBMs marks a pivotal moment in the ongoing effort to reform the healthcare industry and ensure ...

HOUSTON, TX / ACCESSWIRE / July 25, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

Adial Pharmaceuticals Inc (NASDAQ:ADIL) announced the progression to the second cohort in the pharmacokinetics study of AD04.

BioCryst Pharmaceuticals' pipeline includes promising drug candidates in pivotal phases and pre-clinical stages. See why I ...

Nandita Vijayasimha, Bengaluru Wednesday, July 24, 2024, 08:00 Hrs [IST] ...

Adopting sustainable practices in the pharmaceutical industry has many benefits and reduces its environmental impact, such as ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Adial Pharmaceuticals (NASDAQ:ADIL) stock is rocketing higher on Tuesday after ...

Download Sample Report Now- Pharmaceutical Quality Management Systems (QMS) are sets of procedures and practices that ...

Saul Ewing's Sarah A. Sullivan and Alexander Lee Callo in Newark have recently entered appearances on behalf of an artificial ...

Leveraging its patented Micro-Neighborhood ® Targeting (MNT) technology, OptimizeRx delivers marketing campaigns for life sciences brands looking to reach and engage consumers while maintaining ...

Biodexa Pharmaceuticals PLC (NASDAQ ... dosage regime for its phase 3 trial, which the company is gearing up to launch soon.

Cary Claiborne, President and Chief Executive Officer of Adial commented, “We are pleased with the progress of our pharmacokinetics study of AD04. The successful completion of the first cohort allows ...